SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The conversation is dominated by concerns over the market impact of rising 10-year Treasury yields, surging oil prices, and the uncertainty surrounding the Federal Reserve's upcoming rate decision. Traders are also debating the implications of potential AI development slowdowns, with many expressing skepticism regarding corporate AI investments and the sustainability of market valuations.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending following a sector-wide rotation into cybersecurity as investors react to calls for a more measured pace in frontier AI development. While market participants debate the sustainability of the move given the stock's high valuation, the community is split between bullish sentiment driven by the necessity of AI-driven security and bearish skepticism regarding the stock's fundamental pricing.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc - Ordinary Shares - 144A

Nasdaq Inc

Nasdaq Inc. is trending as investors monitor ongoing technical analysis, including Elliott Wave forecasts, and the company's recent strategic moves such as its $100 million investment in Kraken's parent company, Payward. Discussion is also fueled by general market interest in Nasdaq's new initiatives, including the upcoming expansion to 23-hour trading.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as traders react to heightened uncertainty surrounding artificial intelligence development following calls from industry leaders to slow progress, alongside concerns over rising Treasury yields and Middle East tensions. While some investors interpret the AI slowdown as a potential negative for semiconductor names and a catalyst for sector rotation, others view the market's resilience and recovery from early volatility as a sign of underlying buying interest ahead of the upcoming Federal Reserve policy decision.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as traders focus on the upcoming PDUFA date and clinical catalysts for its cancer therapy, ivonescimab. While some investors express confidence in the company's prospects and strong insider ownership, others remain focused on the regulatory risks and the need for successful Phase III readouts to drive significant price action.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

The conversation is highly fragmented and lacks a dominant finance-related catalyst, with discourse primarily revolving around political controversies, allegations of corruption involving the Trump family and foreign figures, and intense debates over social and geopolitical issues.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is trending amid investor optimism surrounding Ethereum's recent performance and the company's progress toward acquiring 5% of the total ETH supply. While some traders express frustration over the stock's volatility and historical underperformance, others view recent treasury updates and potential regulatory developments like the Clarity Act as catalysts for a long-term bull cycle.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing a strong rally driven by robust demand and sellouts for the new foldable 'iPhone Duo' and a refreshed Pro lineup, with sentiment leaning bullish as traders monitor the stock's approach toward its 52-week highs. While many market participants are capitalizing on the momentum through call options, a segment of the community expresses skepticism regarding valuation premiums and questions the long-term impact of the foldable product strategy.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending following a recent initiation of coverage by Rosenblatt, which highlighted the company as an "AI optical powerhouse" with a Buy rating and bullish price target. While retail sentiment remains largely bullish, investors are actively debating the stock's recent volatility and its potential to recover from a sector-wide decline.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

The Breakwave Tanker Shipping ETF is surging as traders respond to intensified geopolitical instability in the Strait of Hormuz, where continued disruptions and tanker attacks are driving freight rates to record highs. While the community is debating whether the rally is reaching a top or has further room to run, many are closely monitoring developments around the strait as the primary catalyst for the fund's extreme volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The community remains deeply divided, with a vocal bearish contingent labeling the stock a scam and highlighting risks of dilution and potential delisting, while a smaller group of bulls discusses potential short-squeeze opportunities and the company's diagnostic product supply deals.

Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement PR...

Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds PR Newswire LONDON, July 10, 2026 LONDON, July 10, 2026...

Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds PR Newswire LONDON, July 9, 2026 LONDON, July 9, 2026 /PRNewswire/ -- Virax...

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular session. The market value of their outstanding shares is at $2.5 million.
Forte Biosciences (NASDAQ:FBRX) stock roseread more...

These Companies Just Dropped Major Growth Catalysts

A wave of corporate announcements, from international distribution agreements and manufacturing leadership appointments to expanding government contracts and enterprise AI initiatives, several companies confirm strengthening revenue opportunities and long-term execution. $BLIS, $VRAX, $ENVX, $RKTO, $SPCX, $TDTH

Virax Biolabs Lands Strategic Southeast Asia Distribution Deal, Opening the Door to Commercial Revenue Across Six Countries

Virax Biolabs (NASDAQ:VRAX) has taken a meaningful step from product development toward commercial execution by signing an exclusive multi-country commercial supply agreement with Fosun Diagnostics, one of Asia's largest diagnostics organizations. While still an emerging biotechnology company, Virax is now positioned to begin generating near-term revenue from its commercially available ImmuneSelect research-use product line while continuing to develop its flagship ViraxImmune diagnostic platform.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's pre-market session. The company's market cap stands at $2.5 million.
Alnylam Pharmaceuticals (NASDAQ:ALNY) stockread more...

Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics

Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics PR Newswire LONDON, July 9, 2026 LONDON, July 9, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the...

Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation

Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation PR Newswire LONDON, June 24, 2026 LONDON, June 24, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that...

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune in Long COVID and Related Post-Acute Infection Syndromes

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune in Long COVID and Related Post-Acute Infection Syndromes Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune in Long COVID and Related Post-Acute Infection Syndromes PR Newswire LONDON, May 26, 2026 LONDON, May 26...

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Virax Biolabs Group Ltd - Ordinary Shares - Class A

Neutral Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Feed

News

Sentiment

Fundamentals

Info

VRAX Virax Biolabs Group Ltd

Fundamentals

Community Summary

Latest VRAX News